Raymond James Positive on Lexeo Therapeutics (LXEO): 'expect shares to trade up'
Tweet Send to a Friend
Raymond James analyst Christopher Raymond reiterated a Strong Buy rating and $25.00 price target on Lexeo Therapeutics (NASDAQ: LXEO).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
